ANSES Revised STS NOTE on the application to cholecalciferol (vitamin D3) of the provisions relating to substances with endocrine-disrupting properties of Act No. 2020-105 of 10 February 2020 (the "AGEC Act")
Fichier
Mots clés
Cholecalciferol, ergocalciferol, vitamin D, hypercalcaemia, endocrine disruptor, endocrine system
Type
Comité d'experts
Numéro de saisine
2022-AST-0099
Date signature
Wednesday, 26 October, 2022
Date publication prévue
Wednesday, 2 November, 2022
Date visa DG
Monday, 3 October, 2022
Date de mise en ligne
Wednesday, 2 November, 2022
Clé(s) d'appartenance
PEE
VIT
Supprimé
non
Sous-titre
Revised STS Note of 26 October 2022
Heure
Thursday, 27 October, 2022 - 10:00